5 certified Labor Condition Applications on file with the U.S. Department of Labor, FY2021–FY2021.
Since September 2025, DOL's Project Firewall opens H-1B investigations without waiting for a complaint. These checkpoints come from Recro Pharma, Inc.'s own public LCA filings (FY2019–FY2021) — the same records an investigator pulls first.
Median offered wage is 0% above the DOL prevailing wage across 5 recent certified LCAs. Paying at the floor is lawful, but it invites the question of whether the wage level itself is right.
Level I is the entry-level prevailing-wage tier and the band DOL's Project Firewall reviews first for misclassification (senior duties filed at an entry-level wage). The national share is 17%.
Each worksite needs its own 10-business-day LCA notice and a PAF record of that posting; a move to a new area of intended employment needs a new LCA before the worker starts there.
No additional recruitment or non-displacement attestations apply.
Public DOL disclosure data can lag actual filings by a quarter. Descriptive only — not legal advice.
Yes — Recro Pharma, Inc. sponsors H-1B workers, with 5 certified LCAs on file (FY2021–FY2021), including 5 in FY2021. The median certified salary is $89,086 (P25 $87,360, P75 $90,126). With a 100% transfer share, this employer actively accepts H-1B transfers. 100% of its certified filings meet or exceed the prevailing wage.
Recro Pharma, Inc. H-1B sponsorship at a glance, from public U.S. DOL LCA disclosure data (FY2021–FY2021).
Certified LCAs are a prerequisite to H-1B petitions, not visa approvals; one LCA can cover multiple workers. Descriptive only — not legal advice.
The shaded band is the middle half of certified salaries (P25–P75); the bar spans the lowest to highest certified salary.
Levels I–IV are DOL prevailing-wage experience tiers; 100% of filings are senior-level (III–IV).
| Fiscal year | Certified | Denied | Withdrawn | Total |
|---|---|---|---|---|
| FY2021 | 5 | 0 | 0 | 5 |
Case dispositions from the U.S. DOL OFLC disclosure files. Withdrawn are LCAs that were certified and later withdrawn by the employer; they still count toward Total.
| Job title | Salary | Level | Location | Filed | Status |
|---|---|---|---|---|---|
Scientist II, Analytical Development I-200-21231-532021 | $90,126/yr | III | Gainesville, GA | Aug 19, 2021 | Certified |
Scientist II, Product Development I-200-21203-476941 | $89,086/yr | IV | Gainesville, GA | Jul 22, 2021 | Certified |
Scientist III, Analytical Development I-200-21179-429539 | $87,360/yr | IV | Gainesville, GA | Jun 28, 2021 | Certified |
Scientist II, Analytical Development I-200-21162-389260 | $87,360/yr | IV | Gainesville, GA | Jun 11, 2021 | Certified |
Scientist II, Analytical Development I-200-21161-384880 | $95,004/yr | IV | Gainesville, GA | Jun 09, 2021 | Certified |
One row per LCA case (its latest version), from U.S. DOL OFLC disclosure data. Salaries are the offered wage, converted to a yearly figure. Certified LCAs are not visa approvals.
Worker positions by LCA filing purpose, summed across FY2021–FY2021 disclosure records.
Most active filing months: Jun and Jul — useful for timing transfer conversations.
Attestations from the employer's own LCA filings (Form ETA-9035), as disclosed by the U.S. DOL.
1 state · 1 city
The same DOL data on this page is what every H-1B sponsor must track for each worker. ElevateStaffing.ai automates it end-to-end:
Get the private PAF / LCA gap check for your own filings — free, one business day — then let ElevateStaffing.ai keep every LCA, PAF, I-9 and I-983 deadline audit-ready.
Get my private gap check →